A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.
Rigante, D., Gaspari, S., Compagnone, A., Stabile, A., Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra)., <<BONE>>, 2007; 2007 (40(6)): 283-283 [http://hdl.handle.net/10807/90820]
Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).
Rigante, DonatoPrimo
;Compagnone, AdelePenultimo
;Stabile, AchilleUltimo
2007
Abstract
A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
